Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.

Our previous studies with B-cell chronic lymphocytic leukemia (B-CLL) have suggested that one of the mechanisms of nitrogen mustard (NM) drug resistance is increased repair of drug-induced damage. We have postulated that recombination may play a crucial role in this process. The human homologue of Rad51, (HsRad51), has homology to the RecA protein in Escherichia coli, which is implicated in recombination repair and induction of DNA repair enzymes. In this report, we have examined the expression and distribution of HsRad51 protein in lymphocytes from patients with B-CLL to see whether the expression of HsRad51 is associated with NM damage to the malignant B lymphocytes, specifically chlorambucil (CLB), which is the standard alkylating agent used to treat patients with B-CLL. We have analyzed the intracellular distribution of HsRad51 protein in these lymphocytes before and after treatment with CLB by immunofluorescence. In vitro CLB treatment induces Rad51 expression, as measured by increased immunopositive staining in all CLL samples. In the CLB-resistant CLL lymphocytes, there was a linear correlation between induction of Rad51 protein at 5.4 microM CLB and the in vitro LD50 dose of CLB. Surprisingly, although it has been reported that Rad51 is induced in S phase and only 10% of cells from cell lines expressed positive immunostaining for Rad51, our CLL lymphocytes, which were not subjected to in vitro drug exposure, were 90% positive for Rad51, despite their nonproliferative state, which suggests that there is chronic activation of the protein. Our results suggest that CLB activates HsRad51-directed recombination repair and that this process may be important in NM drug-induced cytotoxicity.

[1]  P. Hasty,et al.  A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53 , 1996, Molecular and cellular biology.

[2]  J. Game.  DNA double-strand breaks and the RAD50-RAD57 genes in Saccharomyces. , 1993, Seminars in cancer biology.

[3]  Game Jc.  DNA double-strand breaks and the RAD50-RAD57 genes in Saccharomyces. , 1993 .

[4]  P. Jeggo,et al.  Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. , 1991, Mutation research.

[5]  W. Siede,et al.  Repair and processing of DNA damage: a summary of recent progress. , 1996, Mutation research.

[6]  G. Batist,et al.  Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. , 1995, Mutation research.

[7]  E. Witkin.  Ultraviolet-induced mutation and DNA repair. , 1969, Annual review of microbiology.

[8]  D. Ward,et al.  Rad51 expression and localization in B cells carrying out class switch recombination. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Panasci,et al.  DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. , 1998, Blood.

[10]  K. Smith,et al.  Quantitation of the involvement of the recA, recB, recC, recF, recJ, recN, lexA, radA, radB, uvrD, and umuC genes in the repair of X-ray-induced DNA double-strand breaks in Escherichia coli. , 1986, Radiation research.

[11]  K. Ikeo,et al.  Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA , 1993, Nature Genetics.

[12]  R. Chanet,et al.  Semidominant suppressors of Srs2 helicase mutations of Saccharomyces cerevisiae map in the RAD51 gene, whose sequence predicts a protein with similarities to procaryotic RecA proteins , 1992, Molecular and cellular biology.

[13]  A. Shinohara,et al.  Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein , 1992, Cell.

[14]  K. Nakao,et al.  Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Caplan,et al.  Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. , 1989, Biochemical pharmacology.

[16]  P. Baumann,et al.  Human Rad51 Protein Promotes ATP-Dependent Homologous Pairing and Strand Transfer Reactions In Vitro , 1996, Cell.

[17]  H. Yamamoto,et al.  A mouse homolog of the Escherichia coli recA and Saccharomyces cerevisiae RAD51 genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Ward,et al.  Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Weaver,et al.  What to do at an end: DNA double-strand-break repair. , 1995, Trends in genetics : TIG.

[20]  S. Caplan,et al.  Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. , 1988, Cancer research.

[21]  N. Kamada,et al.  S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes. , 1996, Oncogene.

[22]  L. Thompson.  Evidence that mammalian cells possess homologous recombinational repair pathways. , 1996, Mutation research.

[23]  M. Wainberg,et al.  Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. , 1991, Journal of the National Cancer Institute.

[24]  C. Rogers,et al.  Genotoxicity of 1-nitronaphthalene in Chinese hamster V79 cells. , 1991, Mutation research.

[25]  J. L. Biedler.  Drug resistance: genotype versus phenotype--thirty-second G. H. A. Clowes Memorial Award Lecture. , 1994, Cancer research.

[26]  I. Nabi,et al.  AMF-R Tubules Concentrate in a Pericentriolar Microtubule Domain After MSV Transformation of Epithelial MDCK Cells , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  A. Stasiak,et al.  Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. , 1994, The EMBO journal.

[28]  T. Horii,et al.  Organization of the recA gene of Escherichia coli. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Jeggo,et al.  Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agents , 1991 .

[30]  N. Maizels,et al.  Nuclear Rad51 foci induced by DNA damage are distinct from Rad51 foci associated with B cell activation and recombination. , 1997, Experimental cell research.

[31]  S. Chaney,et al.  DNA repair: enzymatic mechanisms and relevance to drug response. , 1996, Journal of the National Cancer Institute.

[32]  K. N. Rajasekharan,et al.  Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. , 1996, Mutation research.

[33]  S. Kaye,et al.  Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. , 1989, Cancer research.

[34]  M. Oshimura,et al.  Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Chanet,et al.  The fate of 8-methoxypsoralen photoinduced crosslinks in nuclear and mitochondrial yeast DNA: comparison of wild-type and repair-deficient strains. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Jeggo,et al.  Menage á trois: Double strand break repair, V(D)J recombination and DNA‐PK , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  T. Ohnishi,et al.  Antisense inhibition of the RAD51 enhances radiosensitivity. , 1996, Biochemical and biophysical research communications.

[38]  J. Hoeijmakers,et al.  Disruption of Mouse RAD54 Reduces Ionizing Radiation Resistance and Homologous Recombination , 1997, Cell.

[39]  L. Morrison,et al.  Mechanism of melphalan resistance developed in vitro in human melanoma cells. , 1981, Cancer research.